Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.890 | 0.938 | 16 | 2007 | 2019 | |||||
Adenocarcinoma of large intestine
|
432 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
Colorectal Neoplasms
|
609 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
Malignant neoplasm of large intestine
|
375 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.040 | 1.000 | 4 | 2014 | 2016 | |||||
Malignant tumor of colon
|
688 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 4 | 2007 | 2018 | |||||
Stomach Carcinoma
|
652 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.040 | 1.000 | 4 | 2014 | 2016 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.030 | 1.000 | 3 | 2014 | 2018 | |||||
Adenoma of large intestine
|
213 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 2 | 2008 | 2013 | |||||
Adenocarcinoma
|
168 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Adenoma
|
103 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of lung
|
1142 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of ovary
|
315 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Nasopharyngeal carcinoma
|
320 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.658 | 0.400 | 8 | 127395198 | intron variant | A/G | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 |